StockData
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) stock

NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 9/30
$35.91−0.53 (-1.45%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Nektar Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nektar Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 15.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.3×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−8.9
2025Dec 31, 20259.8×+6.3
2024Dec 31, 20243.5×+2.8
2023Dec 29, 20230.7×−0.4
2022Dec 30, 20221.0×−2.1
2021Dec 31, 20213.1×+0.5
2020Dec 31, 20202.6×+0.1
2019Dec 31, 20192.5×−0.6
2018Dec 31, 20183.2×−108.2
2017Dec 29, 2017111.4×−218.6
2016Apr 29, 2016330.0×+272.5
2015Dec 31, 201557.5×+15.4
2014Dec 31, 201442.1×+15.5
2013Apr 30, 201326.6×+17.6
2012Dec 31, 20128.9×+6.2
2011Dec 30, 20112.8×–

More Nektar Therapeutics figures

See a number that looks wrong?